Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume
Decrease Volume
Seek Forward
Seek Backward
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Seek %0-9
00:00
00:00
00:00
 

Chapters

Transcript

 

SPEAKER: It's a major problem. Our nation is getting old. We have a higher number of seniors in the last 10 years compared to any time before. In our projection, we find it out that in the next 50 years, the percentage of people aged more than 65 will increase to more than 15% of this population.

In other words, we're going to have early, high risk, susceptible for NTM in near future. That gives us a very important message. The number of NTM patients in the United States will increase in the next 50, 100 years.

Today is the time to make a plan, make infrastructure, train physicians, prepare patients, and ready for this big fight.

As a doctor, what I would suggest is always think about NTM. Screen your patients. React to the disease. Never ignore the report that you receive is NTM, MAC, and other bacteria. And if you need any consult, consult with experts in the field that should be available to you.

Video

What is likely to be the future burden of MAC and NTM lung disease as our populations ages?

What is likely to be the future burden of MAC and NTM lung disease as our populations ages?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Mehdi Mirsaeidi, MD, MPH

Mehdi Mirsaeidi, MD, MPH

Director of University of Miami and VA Sarcoidosis Programs
Co-Director UM NTM Program
IRB Vice-Chairman, Miami VA Healthcare System
Assistant Professor of Department of Medicine
Assistant Professor of Clinical Public Health Sciences
Division of Pulmonary